D. Worah

发表

Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.

G. Elizondo, D. D. Stark, J. Ferrucci, 1991, Radiology.

Binding of recrystallized and chromatographically purified 8-anilino-1-naphthalenesulfonate to Escherichia coli lac repressor.

D. Worah, S. York, R. Lawson, 1978, Biochemistry.

Metal ion release from paramagnetic chelates: What is tolerable?

S. Rocklage, D. Worah, Sook-Hui Kim, 1991, Magnetic resonance in medicine.

Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.

D. Worah, M. Van Wagoner, 1993, Investigative radiology.

A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.

S. Quay, P. Leese, M. VanWagoner, 1991, Investigative radiology.

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

E. Holtz, K. Furuhama, D. Worah, 1993, Investigative radiology.

Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel

P. Constantinides, S. Quay, Steven C. Quay, 2000, Pharmaceutical Research.

Association of Escherichia coli lac repressor with poly[d(A-T)] monitored with 8-anilino-1-napthalenesulfonate.

D. Worah, S. York, L. Yang, 1978, Biochemistry.

Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography.

J. Correas, S. Quay, J M Correas, 2001, Ultrasound in medicine & biology.